Alabama Alaska Arizona Arkansas California Colorado Florida Georgia Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania South Carolina South Dakota Tennessee Texas Utah Vermont Virginia Washington West Virginia Wisconsin Wyoming

About Michael Silber

This author has not yet filled in any details.
So far Michael Silber has created 2529 blog entries.

Tennessee

The deadline to submit an attestation of low-volume status and proof of actual prescription volume to your contracted PBMs is December 1. Volume status is based on your pharmacy’s actual prescription volume from July 1, 2024, to June 30, 2025. For more information, please refer to the Department of Commerce and Insurance (TDCI) rules. The Tennessee Pharmacists Association’s PBM resource page also has some helpful information to assist you with this process.

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2025-11-20T09:57:54-05:00November 20, 2025|Tennessee|

Massachusetts

The Board of Pharmacy shared the following updates. As a reminder, pharmacy practice documents, regulations and other resources are available on the website.  

Policy 2020-15: Scope of Practice  

Updates to this policy define "handling" of medications and that it requires an individual pharmacy license as well as defining the "prescription area" and who may access it.  

New Pharmacy Labeling Requirement 

Pharmacies must now label Schedule VI medications prescribed for reproductive or gender-affirming care with the name and address of the healthcare practice instead of the individual prescriber upon request from the prescriber.  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2025-11-13T08:18:41-05:00November 13, 2025|Massachusetts|

New York

Effective November 6, Yeztugo® was covered as a pharmacy benefit by NYRx, the Medicaid Pharmacy Program, in addition to being covered by the Medicaid managed care medical benefit as a Practitioner-Administered Drug (PAD). To prevent pharmacy claim denial, it is important for the pharmacy to submit the claim for both oral and subcutaneous products on the same date of service.  

For more information, contact NACDS’ Leigh Knotts at 803-243-7207.

2025-11-13T08:18:11-05:00November 13, 2025|New York|

Arizona

The Arizona Medicaid agency, the Arizona Health Care Cost Containment System and the Governor's Office invite you to attend this public webinar to learn more about Arizona's application for the Rural Health Transformation Program. This webinar will highlight the application submitted and will discuss the next steps regarding the program award and the funding of Arizona's programming. Click here to register and add to your calendar.  

Date: November 13  

Time: 11:30 am – 12:30 pm  

Location: Virtual Via Google Meet. Please register in advance. (Meeting ID and passcode will be provided upon registration)  

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2025-11-07T13:51:41-05:00November 7, 2025|Arizona|

California

he Board of Pharmacy distributed its monthly News Roundup for November. This issue includes important information related to vaccines, albuterol and epinephrine standing orders for schools, the California Medication Error Reporting (CAMER), drug theft/drug loss online portal and PIC training webinar. 

Also in California, the November 2025 issue of the Board of Pharmacy's newsletter, The Script, is now published online. The November 2025 newsletter includes information on: 

  • New Laws 
  • Regulations 
  • Immunization Alert 
  • Importance of Patient Consent Forms 
  • CAMER 
  • Inspection Results 
  • Citations Issued 
  • Technology the Pharmacist's Role in Medication Safety 
  • Standing Orders for Schools Regarding Albuterol and Epinephrine 
  • Well-Being Index 

Also in California, the Board of Pharmacy sent the following reminder to licensees.  

Business and Professions Code (BPC) section 4113.1 establishes requirements for a community pharmacy to report medication errors known as CAMER to an entity approved by the Board. The statute requiring medication error reporting by community pharmacies can be viewed at BPC section 4113.1. The Board approved the Institute for Safe Medication Practices (ISMP), an ECRI Company, as the entity to receive and review medication error reports under BPC section 4113.1. Information regarding CAMER registration can be found at https://mederrors.ismp.org/.  

The Board reminds community pharmacy licensees that medication errors that occur on or after September 1, 2025, must be reported to the CAMER system consistent with legal requirements established.  

Also in California, the Department of Health Care Service posted the following on the Medi-Cal Rx Web Portal: 

 

Finally in California, pursuant to the announced pharmacy benefit policy changes effective January 1, 2026, the Department of Health Care Services (DHCS) mailed letters to Medi-Cal members to notify them of two upcoming changes:  

  • All Medi-Cal members received a letter concerning the exclusion of coverage for GLP-1 medications for weight-loss indications. 
  • Impacted Medi-Cal members received a letter concerning the need for prior authorization (PA) approval for select medications previously filled without a PA request. 

 Both letters provide members with information about the policy change and guidance concerning potential actions the member may take. 

Questions may be submitted to the Pharmacy Benefits Division at Medi-Cal.PharmacyBenefits@dhcs.ca.gov or to the Medi-Cal Rx Education and Outreach team at Medicalrxeducationoutreach@primetherapeutics.com 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2025-11-07T13:51:06-05:00November 7, 2025|California|

Iowa

Gov. Kim Reynolds (R) announced the state submitted its application to CMS for the Rural Health Transformation Program. The proposal, titled Healthy Hometowns, is aimed at building a high-quality, sustainable system of care that improves the health, well-being and quality of life in rural communities across the state. Healthy Hometowns is Iowa's strategic response—developed in collaboration with rural hospitals, health systems, and community partners—to address these challenges through a hub and spoke model of care. More information about Iowa's Rural Health Transformation proposal, including its application, is available online.  

Also in Iowa, the Department of Health and Human Services (Iowa HHS) launched a new funding opportunity to help communities across the state respond to the opioid crisis. This funding comes from HF 1038 passed earlier this year, which directs 75% of Iowa's opioid settlement money toward efforts to reduce opioid misuse and its impacts.  

The Iowa HHS will allocate this funding through a competitive application process. There will be two rounds of funding: one starting now and another in the spring. Each project can receive up to $1 million, with $7 million available in each round. 

Projects must focus on one or more of the following goals:  

  • Identifying and addressing needs in communities affected by opioids. 
  • Using proven or community-based methods to support people impacted by opioid use. 
  • Working with local service providers to improve recovery outcomes. 
  • Promoting the use of medications for opioid use disorder (MOUD) and distributing overdose reversal drugs (OORM). 
  • Respecting the privacy and dignity of people receiving services. 
  • Using data to show results and improve services. 

For more information or to apply, visit: https://www.iowagrants.gov/viewStorefrontOpportunity.do?OIDString=1758745329639%7COpportunity 

For more information, contact NACDS’ Sandra Guckian at 703-774-4801.

2025-11-07T13:50:06-05:00November 7, 2025|Iowa|
Go to Top